Compounds > 3-aminobenzamide
Page last updated: 2024-10-21

3-aminobenzamide and Cancer of Ovary

3-aminobenzamide has been researched along with Cancer of Ovary in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (55.56)18.2507
2000's2 (22.22)29.6817
2010's2 (22.22)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, J2
Kan, Y1
Tian, Y1
Wang, Z1
Beauchamp, MC1
Knafo, A1
Yasmeen, A1
Carboni, JM1
Gottardis, MM1
Pollak, MN1
Gotlieb, WH1
Nguewa, PA1
Fuertes, MA1
Cepeda, V1
Alonso, C1
Quevedo, C1
Soto, M1
Pérez, JM1
Bürkle, A1
Chen, G4
Küpper, JH1
Grube, K1
Zeller, WJ4
Boike, GM1
Petru, E1
Sevin, BU1
Averette, HE1
Chou, TC1
Penalver, M1
Donato, D1
Schiano, M1
Hilsenbeck, SG1
Perras, J1
He, YJ1
Liu, RH1
Ning, CQ1
Yu, NF1

Reviews

1 review available for 3-aminobenzamide and Cancer of Ovary

ArticleYear
[Research progresses of the PARP inhibitors for the treatment of cancer].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2013, Volume: 48, Issue:5

    Topics: Animals; Antineoplastic Agents; Benzimidazoles; Breast Neoplasms; DNA Repair; Drug Therapy, Combinat

2013

Other Studies

8 other studies available for 3-aminobenzamide and Cancer of Ovary

ArticleYear
Effects of poly (ADP-ribosyl) polymerase (PARP) inhibitor on cisplatin resistance & proliferation of the ovarian cancer C13* cells.
    The Indian journal of medical research, 2013, Volume: 137, Issue:3

    Topics: Apoptosis; Benzamides; Cell Line, Tumor; Cell Proliferation; Cisplatin; Drug Resistance, Neoplasm; E

2013
BMS-536924 sensitizes human epithelial ovarian cancer cells to the PARP inhibitor, 3-aminobenzamide.
    Gynecologic oncology, 2009, Volume: 115, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Benzamides; Benzimidazoles; Cell Line, Tumor; DNA Da

2009
Poly(ADP-ribose) polymerase-1 inhibitor 3-aminobenzamide enhances apoptosis induction by platinum complexes in cisplatin-resistant tumor cells.
    Medicinal chemistry (Shariqah (United Arab Emirates)), 2006, Volume: 2, Issue:1

    Topics: Animals; Antineoplastic Agents; Apoptosis; Benzamides; Cisplatin; Drug Resistance, Neoplasm; Drug Sy

2006
Increased poly(ADP-ribosyl)ation in intact cells by cisplatin treatment.
    Carcinogenesis, 1993, Volume: 14, Issue:4

    Topics: Animals; Benzamides; Cisplatin; DNA Repair; DNA, Neoplasm; Enzyme Induction; Female; Fluorescent Ant

1993
Multiple effects of 3-aminobenzamide on DNA damage induced by cisplatin (DDP) in DDP-sensitive and -resistant rat ovarian tumor cell lines.
    Cancer letters, 1992, Oct-30, Volume: 67, Issue:1

    Topics: Animals; Benzamides; Cisplatin; DNA; DNA Damage; Drug Resistance; Female; Ovarian Neoplasms; Poly(AD

1992
Chemical enhancement of cisplatin cytotoxicity in a human ovarian and cervical cancer cell line.
    Gynecologic oncology, 1990, Volume: 38, Issue:3

    Topics: Adenosine Triphosphate; Benzamides; Caffeine; Cells, Cultured; Cisplatin; Dose-Response Relationship

1990
In vitro investigations on induction and reversal of cisplatin resistance in a rat ovarian tumor cell line.
    Journal of cancer research and clinical oncology, 1990, Volume: 116, Issue:5

    Topics: Animals; Antimetabolites; Benzamides; Buthionine Sulfoximine; Cell Line; Cisplatin; DNA; Drug Resist

1990
Enhancement of cisplatin (DDP) antitumor activity by 3-aminobenzamide in rat ovarian tumors sensitive and resistant to DDP in vivo.
    Cancer chemotherapy and pharmacology, 1990, Volume: 26, Issue:1

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Cisplatin; Drug Resistance; Dru

1990